Debate on Therapeutic Drug Monitoring in Rheumatoid Arthritis Treatment

This chapter delves into the ongoing discourse surrounding the utilization of therapeutic drug monitoring (TDM) in the treatment of rheumatoid arthritis (RA), exploring varied viewpoints on factors like adverse events, drug options, and cost. It emphasizes the complexities involved in integrating TDM into rheumatology practices and how its relevance persists amidst advancements in RA therapies.